<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03534986</url>
  </required_header>
  <id_info>
    <org_study_id>2017-02</org_study_id>
    <nct_id>NCT03534986</nct_id>
  </id_info>
  <brief_title>Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements</brief_title>
  <official_title>Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Biophysics Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Biophysics Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of high-frequency chest wall oscillation therapy on spirometry values (Forced
      Expiratory Volume, Forced Vital Capacity, Peak Expiratory Flow, Forced Expiratory Flow and
      Tidal Volume is investigated during use of several products and comparing to baseline values.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be broken into three (3) arms:

        -  AffloVest® &amp; The Vest®

        -  AffloVest® &amp; inCourage®

        -  AffloVest® &amp; SmartVest® Subjects will be randomly assigned to an arm. Within each arm,
           the order of products will be also randomized.

      Baseline spirometry (Forced Expiratory Volume (FEV1), Forced Vital Capacity (FVC), Peak
      Expiratory Flow (PEF), Forced Expiratory Flow (FEF25-75%) and Tidal Volume (TV)) will be
      taken at the beginning, middle and end of each series of measurements with each subject,
      without any device on the subject.

      A product (AffloVest or Compressor-based vest) will be placed onto subject and turned ON to
      the highest frequency and intensity settings. Then the subject will be given a certain period
      of time to adjust and spirometry measurements will then be repeated, then The product will be
      removed and the subject will be allowed a recovery period, then the other product will be
      placed on the subject, turned ON and spirometry measurements will repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 20, 2018</start_date>
  <completion_date type="Actual">March 16, 2018</completion_date>
  <primary_completion_date type="Actual">March 16, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TV</measure>
    <time_frame>30 minutes</time_frame>
    <description>Tidal Volume, the lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PEF</measure>
    <time_frame>30 minutes</time_frame>
    <description>Peak Expiratory Flow, a person's maximum speed of expiration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FVC</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Vital Capacity, the amount of air which can be forcibly exhaled from the lungs after taking the deepest breath possible</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Expiratory Volume, the volume of air that can be forced out in one second after taking a deep breath</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEF25-75%</measure>
    <time_frame>30 minutes</time_frame>
    <description>Forced Expiratory Flow (25-75%), the peak expiratory flow at 25 - 75% FVC</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Devices placed on highest intensity / highest frequency</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>International Biophysics AffloVest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hill-Rom The Vest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest The Vest Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Respirtech inCourage</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest inCourage Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electromed SmartVest</intervention_name>
    <description>High-frequency chest wall oscillation vest</description>
    <arm_group_label>AffloVest SmartVest Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subject, ages 18 - 50

        Exclusion Criteria:

          -  Non-ambulatory, diagnosed neuromuscular disorder, currently using any type of
             oscillation vest therapy, diagnosed co-morbid condition (i.e. lung cancer, other lung
             disorder or disease), currently enrolled in a medical research study, non-English
             speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W O'Brien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PDS Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PDS Research</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>May 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2018</study_first_posted>
  <results_first_submitted>August 9, 2018</results_first_submitted>
  <results_first_submitted_qc>August 9, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 6, 2018</results_first_posted>
  <last_update_submitted>September 5, 2018</last_update_submitted>
  <last_update_submitted_qc>September 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 18, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/86/NCT03534986/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>AffloVest The Vest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="P2">
          <title>AffloVest inCourage Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Respirtech inCourage: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="P3">
          <title>AffloVest SmartVest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Electromed SmartVest: High-frequency chest wall oscillation vest</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AffloVest The Vest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="B2">
          <title>AffloVest inCourage Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Respirtech inCourage: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="B3">
          <title>AffloVest SmartVest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Electromed SmartVest: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="12"/>
                    <count group_id="B4" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="12"/>
                    <count group_id="B4" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.4" spread="11.9"/>
                    <measurement group_id="B2" value="30.6" spread="13.3"/>
                    <measurement group_id="B3" value="34.7" spread="10.2"/>
                    <measurement group_id="B4" value="31.7" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="12"/>
                    <count group_id="B4" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="10"/>
                    <count group_id="B2" value="10"/>
                    <count group_id="B3" value="12"/>
                    <count group_id="B4" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>TV</title>
        <description>Tidal Volume, the lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient Baseline Results</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
          </group>
          <group group_id="O3">
            <title>Compressor Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Compressor-type device</description>
          </group>
        </group_list>
        <measure>
          <title>TV</title>
          <description>Tidal Volume, the lung volume representing the normal volume of air displaced between normal inhalation and exhalation when extra effort is not applied</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" lower_limit="0.30" upper_limit="2.32"/>
                    <measurement group_id="O2" value="1.00" lower_limit="0.27" upper_limit="2.28"/>
                    <measurement group_id="O3" value="1.07" lower_limit="0.24" upper_limit="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PEF</title>
        <description>Peak Expiratory Flow, a person's maximum speed of expiration</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient Baseline Results</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
          </group>
          <group group_id="O3">
            <title>Compressor Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Compressor-type device</description>
          </group>
        </group_list>
        <measure>
          <title>PEF</title>
          <description>Peak Expiratory Flow, a person's maximum speed of expiration</description>
          <units>L/s</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.19" lower_limit="3.96" upper_limit="11.82"/>
                    <measurement group_id="O2" value="8.28" lower_limit="3.50" upper_limit="12.00"/>
                    <measurement group_id="O3" value="8.13" lower_limit="4.23" upper_limit="12.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FVC</title>
        <description>Forced Vital Capacity, the amount of air which can be forcibly exhaled from the lungs after taking the deepest breath possible</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient Baseline Results</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
          </group>
          <group group_id="O3">
            <title>Compressor Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Compressor-type device</description>
          </group>
        </group_list>
        <measure>
          <title>FVC</title>
          <description>Forced Vital Capacity, the amount of air which can be forcibly exhaled from the lungs after taking the deepest breath possible</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.29" lower_limit="2.48" upper_limit="6.57"/>
                    <measurement group_id="O2" value="4.25" lower_limit="2.5" upper_limit="7.42"/>
                    <measurement group_id="O3" value="4.12" lower_limit="2.29" upper_limit="6.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FEV1</title>
        <description>Forced Expiratory Volume, the volume of air that can be forced out in one second after taking a deep breath</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient Baseline Results</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
          </group>
          <group group_id="O3">
            <title>Compressor Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Compressor-type device</description>
          </group>
        </group_list>
        <measure>
          <title>FEV1</title>
          <description>Forced Expiratory Volume, the volume of air that can be forced out in one second after taking a deep breath</description>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.51" lower_limit="2.05" upper_limit="5.54"/>
                    <measurement group_id="O2" value="3.46" lower_limit="2.00" upper_limit="6.19"/>
                    <measurement group_id="O3" value="3.30" lower_limit="1.92" upper_limit="5.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>FEF25-75%</title>
        <description>Forced Expiratory Flow (25-75%), the peak expiratory flow at 25 - 75% FVC</description>
        <time_frame>30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Baseline</title>
            <description>Patient Baseline Results</description>
          </group>
          <group group_id="O2">
            <title>AffloVest Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
          </group>
          <group group_id="O3">
            <title>Compressor Arm</title>
            <description>Devices placed on highest intensity / highest frequency
Compressor-type device</description>
          </group>
        </group_list>
        <measure>
          <title>FEF25-75%</title>
          <description>Forced Expiratory Flow (25-75%), the peak expiratory flow at 25 - 75% FVC</description>
          <units>L/s</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.71" lower_limit="1.77" upper_limit="6.43"/>
                    <measurement group_id="O2" value="3.54" lower_limit="1.63" upper_limit="6.37"/>
                    <measurement group_id="O3" value="3.19" lower_limit="1.19" upper_limit="6.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study enrollment, approximately 2 hours.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>AffloVest The Vest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Hill-Rom The Vest: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="E2">
          <title>AffloVest inCourage Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Respirtech inCourage: High-frequency chest wall oscillation vest</description>
        </group>
        <group group_id="E3">
          <title>AffloVest SmartVest Arm</title>
          <description>Devices placed on highest intensity / highest frequency
International Biophysics AffloVest: High-frequency chest wall oscillation vest
Electromed SmartVest: High-frequency chest wall oscillation vest</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>VP of Engineering and Quality</name_or_title>
      <organization>International Biophysics Corporation</organization>
      <phone>512-814-0046</phone>
      <email>quailty@biophysicscorp.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

